Unlike MUC1, IL-22 also regulates MUC13 expression via p38 MAPK activation (Figure 9), a signaling pathway involved in TLR4-mediated cell proliferation and immune dysfunction in IBD [48]. This evidence concerns the gene IL22 and immune system disorder.